{"id":18493,"date":"2017-12-04T11:07:55","date_gmt":"2017-12-04T19:07:55","guid":{"rendered":"https:\/\/sop.washington.edu\/?page_id=18493"},"modified":"2026-04-08T09:55:02","modified_gmt":"2026-04-08T16:55:02","slug":"publications","status":"publish","type":"page","link":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/choice\/research\/research-projects\/icer\/publications\/","title":{"rendered":"Publications"},"content":{"rendered":"

Paroxysmal Nocturnal Hemoglobinuria<\/strong><\/p>\n

Final Evidence Report & Meeting Summary<\/a><\/p>\n

Fahim SM, Makam AN, Suh K, Carlson JJ, Richardson M, Herce-Hagiwara B, et al. Iptacopan and danicopan for paroxysmal nocturnal hemoglobinuria. J Manag Care Spec Pharm. 2024;30(6):618-23. doi: 10.18553\/jmcp.2024.30.6.618. PubMed PMID: 38824627; PubMed Central PMCID: PMC11145001.<\/p>\n

Chronic Obstructive Pulmonary Disease<\/strong><\/p>\n

Final Evidence Report and Meeting Summary<\/a><\/p>\n

Anemia in Myelodysplastic Syndrome<\/strong><\/p>\n

Final Evidence Report and Meeting Summary<\/a><\/p>\n

Fahim SM, Tice JA, Luu L, Carlson JJ, Richardson M, Herce-Hagiwara B, et al. Imetelstat for anemia in lower-risk myelodysplastic syndromes: A summary from the Institute for Clinical and Economic Review’s California Technology Assessment Forum. J Manag Care Spec Pharm. 2024;30(12):1479-85. doi: 10.18553\/jmcp.2024.30.12.1479. PubMed PMID: 39612256; PubMed Central PMCID: PMC11607211.<\/p>\n

Anemia in Chronic Kidney Disease<\/strong><\/p>\n

Final Evidence Report & Meeting Summary<\/a><\/p>\n

Mustafa RA, Bloudek L, Fox G, Carlson JJ, Campbell JD, Agboola F, Pearson SD, Rind DM. Treatments for Anemia in Chronic Kidney Disease: Effectiveness and Value; Final Evidence Report. Institute for Clinical and Economic Review, March 5, 2021. https:\/\/icer.org\/assessment\/anemia-in-chronic-kidney-disease-2021\/#timeline<\/a>.<\/p>\n

Amyotrophic Lateral Sclerosis (ALS)<\/strong><\/p>\n

Final Evidence Report and Meeting Summary<\/a><\/p>\n

Nikitin D, Makam AN, Suh K, et al. The effectiveness and value of AMX0035 and oral edaravone for amyotrophic lateral sclerosis: A summary from the Institute for Clinical and Economic Review’s Midwest Comparative Effectiveness Public Advisory Council. J Manag Care Spec Pharm<\/em>. Feb 2023;29(2):216-221. doi:10.18553\/jmcp.2023.29.2.216<\/p>\n

Non-Alcoholic Steatohepatitis<\/strong><\/p>\n

Evidence Report<\/a><\/p>\n

Fahim SM, Tice JA, Suh K, Carlson JJ, Richardson M, Chu JN, et al. Resmetirom for nonalcoholic steatohepatitis. J Manag Care Spec Pharm. 2023;29(10):1169-72. doi: 10.18553\/jmcp.2023.29.10.1169.<\/p>\n

Metachromatic Leukodystrophy<\/strong><\/p>\n

Final Evidence Report and Meeting Summary<\/a><\/p>\n

Fahim SM, Lin G, Suh K, Carlson JJ, Richardson M, Herce-Hagiwara B, et al. Atidarsagene autotemcel for metachromatic leukodystrophy. J Manag Care Spec Pharm. 2024;30(2):201-5. doi: 10.18553\/jmcp.2024.30.2.201. PubMed PMID: 38308621; PubMed Central PMCID: PMC10838137.<\/p>\n

Non-Small Cell Lung Cancer<\/strong><\/p>\n

Final Evidence Report and Meeting Summary<\/a><\/p>\n

Chemotherapy-Induced Neutropenia<\/strong><\/p>\n

Revised Evidence Report<\/a><\/p>\n

Ulcerative Colitis<\/strong><\/p>\n

Final Evidence Report & Meeting Summary<\/a><\/p>\n

Pandey R, Ollendorf DA, Fazioli K, Bloudek L, Carlson JJ, Pearson SD. The effectiveness and value of targeted immune modulators for moderate to severe ulcerative colitis. J Manag Care Spec Pharm. 2021;27(3):405-10. doi: 10.18553\/jmcp.2021.27.3.405. PubMed PMID: 33645245; PubMed Central PMCID: PMC10391273.<\/p>\n

Bloudek LM, Pandey R, Fazioli K, Ollendorf DA, Carlson JJ. Optimal treatment sequence for targeted immune modulators for the treatment of moderate to severe ulcerative colitis. J Manag Care Spec Pharm. 2021;27(8):1046-55. doi: 10.18553\/jmcp.2021.27.8.1046. PubMed PMID: 34337994; PubMed Central PMCID: PMC10390993.<\/p>\n

Hereditary Angioedema<\/strong><\/p>\n

2021 RWE UPDATE: Final Updated Assessment<\/a><\/p>\n

2018 Final Evidence Report & Meeting Summary<\/a><\/p>\n

Jaksa A, Bloudek L, Carlson JJ, Shah K, Chen Y, Patrick AR, et al. Key learnings from Institute for Clinical and Economic Review’s real-world evidence reassessment pilot. Int J Technol Assess Health Care. 2022;38(1):e32. Epub 20220314. doi: 10.1017\/S0266462322000162. PubMed PMID: 35357284.<\/p>\n

Agboola F, Lubinga S, Carlson JJ, Lin GA, Dreitlein WB, Pearson SD. The Effectiveness and Value of Lanadelumab and C1 Esterase Inhibitors for Prophylaxis of Hereditary Angioedema Attacks. J Manag Care Spec Pharm. 2019;25(2):143-8.<\/p>\n

Prostate Cancer<\/strong><\/p>\n

Final Evidence Report & Meeting Summary<\/a><\/p>\n

Opioid Epidemic: Supervised Injection Facilities<\/strong><\/p>\n

Final Evidence Report<\/a><\/p>\n

Peanut Allergy:<\/strong><\/p>\n

Final Evidence Report<\/a><\/p>\n

Diabetes: Type 2<\/strong><\/p>\n

2022: Final Evidence Report and Meeting Summary<\/a><\/p>\n

2019: Public Comments on Draft Evidence Report<\/a><\/p>\n

Heme A:<\/strong><\/p>\n

Final Evidence Report & Meeting Summary<\/a><\/p>\n

Atopic Dermatitis:<\/strong><\/p>\n

2021: Final Evidence Report and Meeting Summary<\/a><\/p>\n

2017: Atopic Dermatitis: Final Report<\/a><\/p>\n

Agboola F, Atlas SJ, Brouwer E, Carlson JJ, Hansen RN, Herron-Smith S, Nhan E, Rind DM, Pearson SD.\u00a0JAK inhibitors and monoclonal antibodies for the treatment of atopic dermatitis: effectiveness and value.\u00a0J Manag Care Spec Pharm.\u00a02022 Jan;28(1):108-114.\u00a0doi: 10.18553\/jmcp.2022.28.1.108.\u00a0PubMed PMID: 34949111.<\/p>\n

Multiple Myeloma:<\/strong><\/p>\n

Multiple Myeloma: Final Evidence Report and Meeting Summary<\/a><\/p>\n

Carlson JJ, Guzauskas G, Chapman R, et al. Cost-effectiveness of drugs to treat relapsed\/refractory Multiple Myeloma in the U.S. Journal of Managed Care & Specialty Pharmacy. 2017 (In Press).<\/p>\n

Carlson JJ, Guzauskas G, Chapman R, et al. Cost-effectiveness of drugs to treat relapse\/refractory multiple myeloma in the US. Poster presented at: International Society for Pharmacoeconomics and Outcomes Research; May 20-24, 2017; Boston, MA.<\/p>\n

Multiple Sclerosis:<\/strong><\/p>\n

Multiple Sclerosis: Final Evidence Report<\/a><\/p>\n

Synnott PG, Bloudek LM, Sharaf R, Carlson JJ, Pearson SD. The Effectiveness and Value of Siponimod for Secondary Progressive Multiple Sclerosis. J Manag Care Spec Pharm. 2020;26(3):236-9. doi: 10.18553\/jmcp.2020.26.3.236. PubMed PMID: 32105176; PubMed Central PMCID: PMC9476233.<\/p>\n

Brouwer E, Carlson JJ, Zimmermann M. Drug-specific discontinuation rates for available multiple sclerosis treatments. Poster presented at: International Society for Pharmacoeconomics and Outcomes Research; May 20-24, 2017; Boston, MA.<\/p>\n

Strand L, Zimmermann M, Carlson JJ, Hansen RN. Cost-utility of early versus delayed treatment with interferon beta-1b in clinically isolated syndrom (CIS) from a United States (US) payer perspective. Poster presented at: International Society for Pharmacoeconomics and Outcomes Research; May 20-24, 2017; Boston, MA.<\/p>\n

Zimmermann M, Brouwer E, Tice JA, et al. Cost-utility of disease modifying therapies for relapsing-remitting multiple sclerosis. Poster presented at: International Society for Pharmacoeconomics and Outcomes Research; May 20-24, 2017; Boston, MA.<\/p>\n

Osteoporosis:<\/strong><\/p>\n

Osteoporosis: Final Evidence Report<\/a><\/p>\n

Psoriasis:<\/strong><\/p>\n

Psoriasis: Final Evidence Report and Meeting Summary<\/a><\/p>\n

Hendrix N, Ollendorf DA, CHapman R, et al. Cost-effectiveness of targeted therapy for moderate-to-severe plaque psoriasis: an analysis based on an institute for clinical and economic review (ICER) report. Poster presented at: International Society for Pharmacoeconomics and Outcomes Research; May 20-24, 2017; Boston, MA.<\/p>\n

Inherited Retinal Disease:<\/strong><\/p>\n

Voretigene Neparvovec<\/a><\/p>\n

Zimmermann M, Lubinga SJ, Banken R, Rind D, Cramer G, Synnott PG, Chapman RH, Khan S, Carlson JJ. Cost Utility of Voretigene Neparvovec for Biallelic RPE65-Mediated Inherited Retinal Disease. Value Health. 2019;22(2):161-7. doi: 10.1016\/j.jval.2018.09.2841. PubMed PMID: 30711060.<\/p>\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

Paroxysmal Nocturnal Hemoglobinuria Final Evidence Report & Meeting Summary Fahim SM, Makam AN, Suh K, Carlson JJ, Richardson M, Herce-Hagiwara B, et al. Iptacopan and danicopan for paroxysmal nocturnal hemoglobinuria. J Manag Care Spec Pharm….<\/p>\n","protected":false},"author":3,"featured_media":0,"parent":18487,"menu_order":31,"comment_status":"closed","ping_status":"closed","template":"templates\/template-choice-institute.php","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"class_list":["post-18493","page","type-page","status-publish","hentry"],"yoast_head":"\nPublications - School of Pharmacy<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/staff.washington.edu\/twentzel\/wordpress\/choice\/research\/research-projects\/icer\/publications\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Publications - School of Pharmacy\" \/>\n<meta property=\"og:description\" content=\"Paroxysmal Nocturnal Hemoglobinuria Final Evidence Report & Meeting Summary Fahim SM, Makam AN, Suh K, Carlson JJ, Richardson M, Herce-Hagiwara B, et al. Iptacopan and danicopan for paroxysmal nocturnal hemoglobinuria. J Manag Care Spec Pharm....\" \/>\n<meta property=\"og:url\" content=\"https:\/\/staff.washington.edu\/twentzel\/wordpress\/choice\/research\/research-projects\/icer\/publications\/\" \/>\n<meta property=\"og:site_name\" content=\"School of Pharmacy\" \/>\n<meta property=\"article:publisher\" content=\"http:\/\/www.facebook.com\/UWSOP\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-08T16:55:02+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@UW_Pharmacy\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/choice\\\/research\\\/research-projects\\\/icer\\\/publications\\\/\",\"url\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/choice\\\/research\\\/research-projects\\\/icer\\\/publications\\\/\",\"name\":\"Publications - School of Pharmacy\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/#website\"},\"datePublished\":\"2017-12-04T19:07:55+00:00\",\"dateModified\":\"2026-04-08T16:55:02+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/choice\\\/research\\\/research-projects\\\/icer\\\/publications\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/choice\\\/research\\\/research-projects\\\/icer\\\/publications\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/choice\\\/research\\\/research-projects\\\/icer\\\/publications\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute\",\"item\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/choice\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Research\",\"item\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/choice\\\/research\\\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Research Projects\",\"item\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/choice\\\/research\\\/research-projects\\\/\"},{\"@type\":\"ListItem\",\"position\":5,\"name\":\"UW CHOICE and ICER Collaboration\",\"item\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/choice\\\/research\\\/research-projects\\\/icer\\\/\"},{\"@type\":\"ListItem\",\"position\":6,\"name\":\"Publications\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/#website\",\"url\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/\",\"name\":\"University of Washington School of Pharmacy\",\"description\":\"University of Washington\",\"publisher\":{\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/#organization\"},\"alternateName\":\"UW School of Pharmacy\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/#organization\",\"name\":\"University of Washington School of Pharmacy\",\"alternateName\":\"UW School of Pharmacy\",\"url\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/sop.washington.edu\\\/wp-content\\\/uploads\\\/W-Logo.png\",\"contentUrl\":\"https:\\\/\\\/sop.washington.edu\\\/wp-content\\\/uploads\\\/W-Logo.png\",\"width\":526,\"height\":527,\"caption\":\"University of Washington School of Pharmacy\"},\"image\":{\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"http:\\\/\\\/www.facebook.com\\\/UWSOP\",\"https:\\\/\\\/x.com\\\/UW_Pharmacy\",\"https:\\\/\\\/www.instagram.com\\\/uw_pharmacy\\\/\",\"https:\\\/\\\/www.youtube.com\\\/user\\\/UWPharmacySchool\",\"https:\\\/\\\/www.linkedin.com\\\/groups\\\/3820716\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Publications - School of Pharmacy","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/choice\/research\/research-projects\/icer\/publications\/","og_locale":"en_US","og_type":"article","og_title":"Publications - School of Pharmacy","og_description":"Paroxysmal Nocturnal Hemoglobinuria Final Evidence Report & Meeting Summary Fahim SM, Makam AN, Suh K, Carlson JJ, Richardson M, Herce-Hagiwara B, et al. Iptacopan and danicopan for paroxysmal nocturnal hemoglobinuria. J Manag Care Spec Pharm....","og_url":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/choice\/research\/research-projects\/icer\/publications\/","og_site_name":"School of Pharmacy","article_publisher":"http:\/\/www.facebook.com\/UWSOP","article_modified_time":"2026-04-08T16:55:02+00:00","twitter_card":"summary_large_image","twitter_site":"@UW_Pharmacy","twitter_misc":{"Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/choice\/research\/research-projects\/icer\/publications\/","url":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/choice\/research\/research-projects\/icer\/publications\/","name":"Publications - School of Pharmacy","isPartOf":{"@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/#website"},"datePublished":"2017-12-04T19:07:55+00:00","dateModified":"2026-04-08T16:55:02+00:00","breadcrumb":{"@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/choice\/research\/research-projects\/icer\/publications\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/staff.washington.edu\/twentzel\/wordpress\/choice\/research\/research-projects\/icer\/publications\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/choice\/research\/research-projects\/icer\/publications\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/"},{"@type":"ListItem","position":2,"name":"The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute","item":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/choice\/"},{"@type":"ListItem","position":3,"name":"Research","item":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/choice\/research\/"},{"@type":"ListItem","position":4,"name":"Research Projects","item":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/choice\/research\/research-projects\/"},{"@type":"ListItem","position":5,"name":"UW CHOICE and ICER Collaboration","item":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/choice\/research\/research-projects\/icer\/"},{"@type":"ListItem","position":6,"name":"Publications"}]},{"@type":"WebSite","@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/#website","url":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/","name":"University of Washington School of Pharmacy","description":"University of Washington","publisher":{"@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/#organization"},"alternateName":"UW School of Pharmacy","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/#organization","name":"University of Washington School of Pharmacy","alternateName":"UW School of Pharmacy","url":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/#\/schema\/logo\/image\/","url":"https:\/\/sop.washington.edu\/wp-content\/uploads\/W-Logo.png","contentUrl":"https:\/\/sop.washington.edu\/wp-content\/uploads\/W-Logo.png","width":526,"height":527,"caption":"University of Washington School of Pharmacy"},"image":{"@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/#\/schema\/logo\/image\/"},"sameAs":["http:\/\/www.facebook.com\/UWSOP","https:\/\/x.com\/UW_Pharmacy","https:\/\/www.instagram.com\/uw_pharmacy\/","https:\/\/www.youtube.com\/user\/UWPharmacySchool","https:\/\/www.linkedin.com\/groups\/3820716"]}]}},"acf":[],"_links":{"self":[{"href":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-json\/wp\/v2\/pages\/18493","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-json\/wp\/v2\/comments?post=18493"}],"version-history":[{"count":0,"href":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-json\/wp\/v2\/pages\/18493\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-json\/wp\/v2\/pages\/18487"}],"wp:attachment":[{"href":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-json\/wp\/v2\/media?parent=18493"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}